Search
Search
Invitrogen
{{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.promotions']}}
{{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.viewpromo']}}
{{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.promocode']}}: {{promo.promoCode}} {{promo.promoTitle}} {{promo.promoDescription}}. {{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.learnmore']}}
图: 1 / 1
Sulfa synergist agents, such as sulfamethoxazole, are known for their ability to enhance the antibacterial effects of other drugs, particularly trimethoprim. This synergistic effect is achieved through the simultaneous binding of both drugs to the bacterial enzyme dihydrofolate reductase, leading to a more potent inhibition of bacterial growth. Sulfa drugs are synthetic bacteriostatic antimicrobials that were widely used before the advent of penicillin. They function by interfering with the synthesis of folate within bacterial cells, a crucial component for bacterial DNA replication and cell division. The combination of sulfa drugs with trimethoprim is particularly effective against Escherichia coli and other bacterial infections, providing a chemotherapeutic potentiation that enhances the overall efficacy of treatment.
仅用于科研。不用于诊断过程。未经明确授权不得转售。